Fintepla and Speech disorder - a phase IV clinical study of FDA data

Summary:

Speech disorder is reported as a side effect among people who take Fintepla (fenfluramine hydrochloride), especially for people who are female, 30-39 old, also take Zarontin, and have Lennox-gastaut syndrome.

The phase IV clinical study analyzes which people have Speech disorder when taking Fintepla. It is created by eHealthMe based on reports of 2,612 people who have side effects when taking Fintepla from the FDA, and is updated regularly.

What is Fintepla?

Fintepla has active ingredients of fenfluramine hydrochloride. eHealthMe is studying from 2,613 Fintepla users. Check the latest studies of Fintepla.

What is Speech disorder?

Speech disorder is found to be associated with 1,806 drugs and 2,281 conditions by eHealthMe. Check the latest studies of Speech disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

2,612 people reported to have side effects when taking Fintepla.
Among them, 16 people (0.61%) have Speech disorder.

Among these 16 people:

What is the gender of people who have Speech disorder when taking Fintepla? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Speech disorder when taking Fintepla? *

What are other drugs people take besides Fintepla? *

What are other side effects people have besides Speech disorder? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 62.50%
Fatigue (feeling of tiredness): 8 people, 50.00%
Feeling Abnormal: 8 people, 50.00%
Gait Disturbance: 7 people, 43.75%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 37.50%
Insomnia (sleeplessness): 5 people, 31.25%
Kidney Stones: 4 people, 25.00%
Urination - Painful: 4 people, 25.00%
Ammonia Abnormal: 4 people, 25.00%
Anticonvulsant Drug Level Abnormal: 4 people, 25.00%

What are the existing conditions these people have? *

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 6 people, 37.50%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 25.00%
Partial Seizures (seizures which affect only a part of the brain at onset): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Fintepla and have Speech disorder?

- Check whether Speech disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fintepla:

Fintepla (2,613 reports)

Speech disorder treatments and more:

Speech disorder (62,574 reports)

Browse all side effects of Fintepla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech disorder:

Speech disorder (1,806 drugs)

Browse all the conditions that are associated with Speech disorder:

Speech disorder (2,281 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenfluramine hydrochloride (the active ingredients of Fintepla) and Fintepla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.